Tag: ADOCIA
Adocia strengthens its cash position by 19 million euros following a real estate transaction – 03/28/2022 at 18:16
(AOF) – Adocia, a clinical-stage biopharmaceutical company, has announced the completion of the sale of its laboratory and office complex, located in Lyon, France, to a specialized investor. This financial…
ADOCIA announces the half-year results of the Adocia liquidity contract entered into with Kepler Capital Markets – 01/13/2022 at 6:00 p.m.
6:00 p.m. CET – Under the liquidity contract entrusted to Kepler Capital Markets relating to the shares of ADOCIA, the following resources appeared in the liquidity account on December 31,…
Adocia: 2022 financial agenda
Through Alexandra Saintpierre Posted on 01/10/2022 3:16 PM Photo credit © Adocia / Tournaire (Boursier.com) – Adocia SA announces its financial calendar for the year 2022. The broadcasts will be…
ADOCIA: Information relating to the number of shares and voting rights on December 31, 2021 – 01/11/2022 at 6:00 p.m.
6:00 p.m. CET – In accordance with the provisions of article L.233-8 II of the French Commercial Code and article 223-16 of the General Regulations of the Autorité des Marchés…
ADOCIA announces its participation in investor conferences in January 2022 – 12/20/2021 at 6:00 p.m.
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), the clinical-stage biopharmaceutical company specializing in the development of innovative peptide and protein formulations for the treatment of diabetes and…